0001209191-18-042624.txt : 20180716
0001209191-18-042624.hdr.sgml : 20180716
20180716160539
ACCESSION NUMBER: 0001209191-18-042624
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180702
FILED AS OF DATE: 20180716
DATE AS OF CHANGE: 20180716
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: TSANG Benson Kwan Hung
CENTRAL INDEX KEY: 0001745135
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38112
FILM NUMBER: 18954526
MAIL ADDRESS:
STREET 1: C/O ATHENEX, INC.
STREET 2: 1001 MAIN STREET, SUITE 600
CITY: BUFFALO
STATE: NY
ZIP: 14203
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Athenex, Inc.
CENTRAL INDEX KEY: 0001300699
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 431985966
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1001 MAIN STREET
STREET 2: SUITE 600
CITY: BUFFALO
STATE: NY
ZIP: 14203
BUSINESS PHONE: 716-898-8625
MAIL ADDRESS:
STREET 1: 1001 MAIN STREET
STREET 2: SUITE 600
CITY: BUFFALO
STATE: NY
ZIP: 14203
FORMER COMPANY:
FORMER CONFORMED NAME: Kinex Pharmaceuticals, Inc.
DATE OF NAME CHANGE: 20131223
FORMER COMPANY:
FORMER CONFORMED NAME: Kinex Pharmaceuticals LLC
DATE OF NAME CHANGE: 20040817
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-07-02
0
0001300699
Athenex, Inc.
ATNX
0001745135
TSANG Benson Kwan Hung
C/O ATHENEX, INC.
1001 MAIN STREET, SUITE 600
BUFFALO
NY
14203
1
0
0
0
Stock Option (Right to Buy)
19.51
2018-07-02
4
A
0
9750
0.00
A
2028-07-02
Common Stock
9750
9750
D
The option vests in four equal annual installments beginning on July 2, 2019.
/s/ Teresa Bair, Attorney-in-Fact
2018-07-16